Compound atlas
Performance

SR9009

Also known as · Stenabolic

REV-ERB agonist
Half-life
4h
approx. mean t½
Dose range
10–30 mg
typical, not prescriptive
Category
Performance
primary use-case
Single-dose decay
t½ = 4h · first-order model
~16h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m4h8h12h16h20h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A REV-ERB agonist (not a SARM) studied as an 'exercise mimetic' for endurance and metabolism. Poor oral bioavailability; banned in sport.

Mechanism of action

Activates REV-ERBα/β to boost mitochondrial activity and shift circadian-metabolic programs.

Typical protocol

10–30 mg/day in split doses due to its short half-life.

Storage

Room temp, dry, away from light.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.